-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on CVS Health, Lowers Price Target to $112

Benzinga·11/12/2026 14:14:27
Listen to the news
Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $123 to $112.